Evidence map›Paper›PMID 35925965›Full record

ArticlePloS one2022

Hepatic transcript signatures predict atherosclerotic lesion burden prior to a 2-year high cholesterol, high fat diet challenge.

Sobha Puppala, Kimberly D Spradling-Reeves, Jeannie Chan, Shifra Birnbaum, Deborah E Newman, Anthony G Comuzzie, Michael C Mahaney, John L VandeBerg, Michael Olivier, Laura A Cox

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Sobha PuppalaCenter for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.ORCID 0000-0002-2766-155X
Kimberly D Spradling-ReevesCenter for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.ORCID 0000-0002-8456-692X
Jeannie ChanCenter for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
Shifra BirnbaumTexas Biomedical Research Institute, San Antonio, Texas, United States of America.
Deborah E NewmanTexas Biomedical Research Institute, San Antonio, Texas, United States of America.ORCID 0000-0003-4025-6601
Anthony G ComuzzieThe Obesity Society, Silver Spring, Maryland, United States of America.
Michael C MahaneySouth Texas Diabetes and Obesity Institute and Department of Human Genetics, The University of Texas Rio Grande Valley School of Medicine, Brownsville, Texas, United States of America.
John L VandeBergSouth Texas Diabetes and Obesity Institute and Department of Human Genetics, The University of Texas Rio Grande Valley School of Medicine, Brownsville, Texas, United States of America.ORCID 0000-0002-7087-979X
Michael OlivierCenter for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.
Laura A CoxCenter for Precision Medicine, Wake Forest School of Medicine, Winston-Salem, North Carolina, United States of America.ORCID 0000-0002-8836-3783
Wake Forest University · USTexas Biomedical Research Institute · USThe University of Texas Rio Grande Valley · USObesity Society · US

Funding

The Southwest National Primate Research Center Supplement- Infrastructure improvements of ABSL2 holding areasP51OD011133 · OD · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI Larry S. Schlesinger · 2012 to 2026
$129.7M
WNV REPLIVAX VACCINE IN NON-HUMAN PRIMATESP51RR013986 · NCRR · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI GOLDBERG, ERWIN · 1999 to 2011
$79.1M
VETERINARY SERVICES--COREP01HL028972 · NHLBI · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI RICE, KAREN S · 1985 to 2012
$42.0M
EXTRAMULAR RESEARCH FACILITIES CONSTRUCTIONC06RR017515 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI SHADE, ROBERT E · 2003 to 2003
$3.1M
EXTRAMURAL RES FACILITIES CONSTRC06RR015456 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI VANDEBERG, JOHN L · 2001 to 2001
$1.1M
MOLECULAR AND BIOCHEMICAL GENETICS LABORATORY RENOVATIONC06RR013556 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI SHADE, ROBERT E · 1998 to 1998
–
BABOON F-CAGE FACILITY FOR PRIMATE RESEARCH CENTERC06RR014578 · NCRR · SOUTHWEST FOUNDATION FOR BIOMEDICAL RES · PI VANDEBERG, JOHN L · 1999 to 1999
–
NCRR NIH HHS C06 RR013556NCRR NIH HHS C06 RR014578NCRR NIH HHS C06 RR015456NCRR NIH HHS C06 RR017515NCRR NIH HHS P51 RR013986NHLBI NIH HHS P01 HL028972NIH HHS P51 OD011133
6 · The paper itself

Abstract

The purpose of this study was to identify molecular mechanisms by which the liver influences total lesion burden in a nonhuman primate model (NHP) of cardiovascular disease with acute and chronic feeding of a high cholesterol, high fat (HCHF) diet. Baboons (47 females, 64 males) were fed a HCHF diet for 2 years (y); liver biopsies were collected at baseline, 7 weeks (w) and 2y, and lesions were quantified in aortic arch, descending aorta, and common iliac at 2y. Unbiased weighted gene co-expression network analysis (WGCNA) revealed several modules of hepatic genes correlated with lesions at different time points of dietary challenge. Pathway and network analyses were performed to study the roles of hepatic module genes. More significant pathways were observed in males than females. In males, we found modules enriched for genes in oxidative phosphorylation at baseline, opioid signaling at 7w, and EIF2 signaling and HNF1A and HNF4A networks at baseline and 2y. One module enriched for fatty acid β oxidation pathway genes was found in males and females at 2y. To our knowledge, this is the first study of a large NHP cohort to identify hepatic genes that correlate with lesion burden. Correlations of baseline and 7w module genes with lesions at 2y were observed in males but not in females. Pathway analyses of baseline and 7w module genes indicate EIF2 signaling, oxidative phosphorylation, and μ-opioid signaling are possible mechanisms that predict lesion formation induced by HCHF diet consumption in males. Our findings of coordinated hepatic transcriptional response in male baboons but not female baboons indicate underlying molecular mechanisms differ between female and male primate atherosclerosis.

Indexed as

AtherosclerosisDiet, High-FatAnalgesics, OpioidAnimalsCholesterolEukaryotic Initiation Factor-2FemaleLiverMalePapioAnalgesics, OpioidCholesterolEukaryotic Initiation Factor-2

Identifiers

PMID35925965
PMCPMC9352111
OpenAlexW4289850482

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.